Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Avax Technologies and Neptunus execute joint venture agreement

Dec. 3, 1999

Schering in-licenses human antibody for gastric cancer

Dec. 2, 1999

Biomira enters collaborative agreement, licenses two patents for cancer vaccine

Nov. 29, 1999

Preliminary survival data from single Maxamine site submitted to ASCO

Nov. 24, 1999

AAPS news: clinical pharmacokinetic analysis of B43-genistein in patients

Nov. 23, 1999

Novel prostate cancer therapy in development at Procyon detailed at international conference

Nov. 23, 1999

NY-ESO-1-derived peptides and their use in cancer therapy and diagnosis

Nov. 23, 1999

StressGen to codevelop HspE7 with NCI for HPV diseases

Nov. 17, 1999

First approval granted for Melacine melanoma therapeutic vaccine

Nov. 5, 1999

Maxamine in combination with IL-2 shows positive results in brain cancer model

Nov. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...